Apolipoprotein C-II Mimetic Peptide Promotes the Plasma Clearance of Triglyceride-Rich Lipid Emulsion and the Incorporation of Fatty Acids into Peripheral Tissues of Mice
Aim. Plasma apolipoprotein C-II (apoC-II) activates lipoprotein lipase (LPL) and thus lowers plasma triglycerides (TG). We previously reported that a human apoC-II mimetic peptide (C-II-a) decreased plasma TG in apoC-II mutant mice, as well as in apoE-knockout mice. Because it is unknown what tissue...
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Journal of Nutrition and Metabolism |
Online Access: | http://dx.doi.org/10.1155/2019/7078241 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832554680780062720 |
---|---|
author | Tomohiro Komatsu Toshihiro Sakurai Anna Wolska Marcelo J. Amar Akiko Sakurai Boris L. Vaisman Denis Sviridov Stephen Demosky Milton Pryor Katsunori Ikewaki Alan T. Remaley |
author_facet | Tomohiro Komatsu Toshihiro Sakurai Anna Wolska Marcelo J. Amar Akiko Sakurai Boris L. Vaisman Denis Sviridov Stephen Demosky Milton Pryor Katsunori Ikewaki Alan T. Remaley |
author_sort | Tomohiro Komatsu |
collection | DOAJ |
description | Aim. Plasma apolipoprotein C-II (apoC-II) activates lipoprotein lipase (LPL) and thus lowers plasma triglycerides (TG). We previously reported that a human apoC-II mimetic peptide (C-II-a) decreased plasma TG in apoC-II mutant mice, as well as in apoE-knockout mice. Because it is unknown what tissues take up free fatty acids (FFAs) released from TG after C-II-a peptide administration, we investigated in mice TG plasma clearance and tissue incorporation, using 3H-triolein as a tracer, with and without C-II-a treatment. Methods and Results. Intralipid® fat emulsion was labeled with 3H-triolein and then mixed with or without C-II-a. Addition of the peptide did not alter mean particle size of the lipid emulsion particles (298 nm) but accelerated their plasma clearance. After intravenous injection into C57BL/6N mice, the plasma half-life of the 3H-triolein for control and C-II-a treated emulsions was 18.3 ± 2.2 min and 14.8 ± 0.1 min, respectively. In apoC-II mutant mice, the plasma half-life of 3H-triolein for injected control and C-II-a treated emulsions was 30.1 ± 0.1 min and 14.8 ± 0.1 min, respectively. C57BL/6N and apoC-II mutant mice at 120 minutes after the injection showed increased tissue incorporation of radioactivity in white adipose tissue when C-II-a treated emulsion was used. Higher radiolabeled uptake of lipids from C-II-a treated emulsion was also observed in the skeletal muscle of C57BL/6N mice only. In case of apoC-II mutant mice, decreased uptake of radioactive lipids was observed in the liver and kidney after addition of C-II-a to the lipid emulsion. Conclusions. C-II-a peptide promotes the plasma clearance of TG-rich lipid emulsions in wild type and apoC-II mutant mice and promotes the incorporation of fatty acids from TG in the lipid emulsions into specific peripheral tissues. |
format | Article |
id | doaj-art-9790458bbef445e190cc1a1f8f281325 |
institution | Kabale University |
issn | 2090-0724 2090-0732 |
language | English |
publishDate | 2019-01-01 |
publisher | Wiley |
record_format | Article |
series | Journal of Nutrition and Metabolism |
spelling | doaj-art-9790458bbef445e190cc1a1f8f2813252025-02-03T05:50:52ZengWileyJournal of Nutrition and Metabolism2090-07242090-07322019-01-01201910.1155/2019/70782417078241Apolipoprotein C-II Mimetic Peptide Promotes the Plasma Clearance of Triglyceride-Rich Lipid Emulsion and the Incorporation of Fatty Acids into Peripheral Tissues of MiceTomohiro Komatsu0Toshihiro Sakurai1Anna Wolska2Marcelo J. Amar3Akiko Sakurai4Boris L. Vaisman5Denis Sviridov6Stephen Demosky7Milton Pryor8Katsunori Ikewaki9Alan T. Remaley10Lipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USALipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USALipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USALipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USALipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USALipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USALipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USALipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USALipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USADivision of Anti-aging and Vascular Medicine, Department of Internal Medicine, National Defense Medical College, Tokorozawa, JapanLipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USAAim. Plasma apolipoprotein C-II (apoC-II) activates lipoprotein lipase (LPL) and thus lowers plasma triglycerides (TG). We previously reported that a human apoC-II mimetic peptide (C-II-a) decreased plasma TG in apoC-II mutant mice, as well as in apoE-knockout mice. Because it is unknown what tissues take up free fatty acids (FFAs) released from TG after C-II-a peptide administration, we investigated in mice TG plasma clearance and tissue incorporation, using 3H-triolein as a tracer, with and without C-II-a treatment. Methods and Results. Intralipid® fat emulsion was labeled with 3H-triolein and then mixed with or without C-II-a. Addition of the peptide did not alter mean particle size of the lipid emulsion particles (298 nm) but accelerated their plasma clearance. After intravenous injection into C57BL/6N mice, the plasma half-life of the 3H-triolein for control and C-II-a treated emulsions was 18.3 ± 2.2 min and 14.8 ± 0.1 min, respectively. In apoC-II mutant mice, the plasma half-life of 3H-triolein for injected control and C-II-a treated emulsions was 30.1 ± 0.1 min and 14.8 ± 0.1 min, respectively. C57BL/6N and apoC-II mutant mice at 120 minutes after the injection showed increased tissue incorporation of radioactivity in white adipose tissue when C-II-a treated emulsion was used. Higher radiolabeled uptake of lipids from C-II-a treated emulsion was also observed in the skeletal muscle of C57BL/6N mice only. In case of apoC-II mutant mice, decreased uptake of radioactive lipids was observed in the liver and kidney after addition of C-II-a to the lipid emulsion. Conclusions. C-II-a peptide promotes the plasma clearance of TG-rich lipid emulsions in wild type and apoC-II mutant mice and promotes the incorporation of fatty acids from TG in the lipid emulsions into specific peripheral tissues.http://dx.doi.org/10.1155/2019/7078241 |
spellingShingle | Tomohiro Komatsu Toshihiro Sakurai Anna Wolska Marcelo J. Amar Akiko Sakurai Boris L. Vaisman Denis Sviridov Stephen Demosky Milton Pryor Katsunori Ikewaki Alan T. Remaley Apolipoprotein C-II Mimetic Peptide Promotes the Plasma Clearance of Triglyceride-Rich Lipid Emulsion and the Incorporation of Fatty Acids into Peripheral Tissues of Mice Journal of Nutrition and Metabolism |
title | Apolipoprotein C-II Mimetic Peptide Promotes the Plasma Clearance of Triglyceride-Rich Lipid Emulsion and the Incorporation of Fatty Acids into Peripheral Tissues of Mice |
title_full | Apolipoprotein C-II Mimetic Peptide Promotes the Plasma Clearance of Triglyceride-Rich Lipid Emulsion and the Incorporation of Fatty Acids into Peripheral Tissues of Mice |
title_fullStr | Apolipoprotein C-II Mimetic Peptide Promotes the Plasma Clearance of Triglyceride-Rich Lipid Emulsion and the Incorporation of Fatty Acids into Peripheral Tissues of Mice |
title_full_unstemmed | Apolipoprotein C-II Mimetic Peptide Promotes the Plasma Clearance of Triglyceride-Rich Lipid Emulsion and the Incorporation of Fatty Acids into Peripheral Tissues of Mice |
title_short | Apolipoprotein C-II Mimetic Peptide Promotes the Plasma Clearance of Triglyceride-Rich Lipid Emulsion and the Incorporation of Fatty Acids into Peripheral Tissues of Mice |
title_sort | apolipoprotein c ii mimetic peptide promotes the plasma clearance of triglyceride rich lipid emulsion and the incorporation of fatty acids into peripheral tissues of mice |
url | http://dx.doi.org/10.1155/2019/7078241 |
work_keys_str_mv | AT tomohirokomatsu apolipoproteinciimimeticpeptidepromotestheplasmaclearanceoftriglyceriderichlipidemulsionandtheincorporationoffattyacidsintoperipheraltissuesofmice AT toshihirosakurai apolipoproteinciimimeticpeptidepromotestheplasmaclearanceoftriglyceriderichlipidemulsionandtheincorporationoffattyacidsintoperipheraltissuesofmice AT annawolska apolipoproteinciimimeticpeptidepromotestheplasmaclearanceoftriglyceriderichlipidemulsionandtheincorporationoffattyacidsintoperipheraltissuesofmice AT marcelojamar apolipoproteinciimimeticpeptidepromotestheplasmaclearanceoftriglyceriderichlipidemulsionandtheincorporationoffattyacidsintoperipheraltissuesofmice AT akikosakurai apolipoproteinciimimeticpeptidepromotestheplasmaclearanceoftriglyceriderichlipidemulsionandtheincorporationoffattyacidsintoperipheraltissuesofmice AT borislvaisman apolipoproteinciimimeticpeptidepromotestheplasmaclearanceoftriglyceriderichlipidemulsionandtheincorporationoffattyacidsintoperipheraltissuesofmice AT denissviridov apolipoproteinciimimeticpeptidepromotestheplasmaclearanceoftriglyceriderichlipidemulsionandtheincorporationoffattyacidsintoperipheraltissuesofmice AT stephendemosky apolipoproteinciimimeticpeptidepromotestheplasmaclearanceoftriglyceriderichlipidemulsionandtheincorporationoffattyacidsintoperipheraltissuesofmice AT miltonpryor apolipoproteinciimimeticpeptidepromotestheplasmaclearanceoftriglyceriderichlipidemulsionandtheincorporationoffattyacidsintoperipheraltissuesofmice AT katsunoriikewaki apolipoproteinciimimeticpeptidepromotestheplasmaclearanceoftriglyceriderichlipidemulsionandtheincorporationoffattyacidsintoperipheraltissuesofmice AT alantremaley apolipoproteinciimimeticpeptidepromotestheplasmaclearanceoftriglyceriderichlipidemulsionandtheincorporationoffattyacidsintoperipheraltissuesofmice |